Tube of SMAP29 peptide
Peptides

SMAP 29, Sheep Myeloid Antimicrobial Peptide 29 - 1 mg

€281.00
Check your price
  • Cat.Number : AS-61308
  • Availability :
    In stock

Quantity

Add to wishlist

This 29 amino acid sheep myeloid antimicrobial peptide 29 (SMAP 29) displays extremely high antimicrobial activity against Pseudomonas strains, other gram-negative bacteria, and multidrug-resistant pathogens. SMAP 29 is a broad-spectrum antibiotic cathelicidin, it is active in both low- and high-ionic-strength conditions, and induces significant morphological alterations in bacterial surfaces.

Specifications

Chemistry
Sequence one letter code
  • RGLRRLGRKIAHGVKKYGPTVLRIIRIAG
Sequence three letter code
  • H-Arg-Gly-Leu-Arg-Arg-Leu-Gly-Arg-Lys-Ile-Ala-His-Gly-Val-Lys-Lys-Tyr-Gly-Pro-Thr-Val-Leu-Arg-Ile-Ile-Arg-Ile-Ala-Gly-OH
Molecular Formula
  • C146H260N52O32
Molecular Mass/ Weight
  • 3256
Modification
Conjugation
  • Unconjugated
Quantity & Purity
Purity
  • ≥ 95%
Storage & stability
Form
  • Lyophilized
Activity
Biomarker Target
Research Area
Sub-category Research Area
Usage
  • Research use
Source
Source / Species
  • sheep
Codes
Code Nacres
  • NA.26

Downloads

You may also be interested in the following product(s)

Tube of flg22 peptide, Flagellin Fragment

flg22, Flagellin Fragment - 1 mg

Cat.Number : AS-62633
€219.00 Excl. Tax
Tube of hBD-1 peptide, ?-Defensin-1 peptide, human

hBD-1, b-Defensin-1, human - 0.1 mg

Cat.Number : AS-60740
€374.00 Excl. Tax
Tube of LL-37 peptide, human

LL-37, Antimicrobial Peptide, human - 1 mg

Cat.Number : AS-61302
€221.00 Excl. Tax

Citations

Screening Antimicrobial Peptides In Vitro for Use in Developing Transgenic Citrus Resistant to Huanglongbing and Citrus Canker

Ameri Soci Horticul Sci . 2013 Mar 01 ; 138(2) 142 | DOI : https://doi.org/10.21273/JASHS.138.2.142

  • E. Stover
  • et al

Acyl carrier protein is a bacterial cytoplasmic target of cationic antimicrobial peptide LL-37

Biochem J . 2015 Jul 17 ; 470(2) 243 | DOI : 10.1042/BJ20150432.

  • MC. Chung
  • et al

Clostridium difficile clinical isolates exhibit variable susceptibility and proteome alterations upon exposure to mammalian cationic antimicrobial peptides.

Anaerobe . 2012 Sep 24 ; 18(6) 614 | DOI : 10.1074/jbc.M110.206110

  • R. McQuade
  • et al